# Booking Holdings Inc.: financial statements, quarterly

BKNG · Nasdaq · CIK 1075531 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bkng.md) · [Financials](/companies/bkng/financials.md) · [Filings](/companies/bkng/filings.md) · [Insiders](/companies/bkng/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bkng/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [7,341](/filings/0001075531-24-000048.md) | [4,784 d](/filings/0001075531-26-000009.md) | [4,415](/filings/0001075531-25-000024.md) | [5,859](/filings/0001075531-25-000036.md) | [7,994](/filings/0001075531-25-000051.md) | [5,471 d](/filings/0001075531-26-000009.md) | [4,762](/filings/0001075531-26-000025.md) | [6,798](/filings/0001075531-26-000037.md) | [9,008](/filings/0001075531-25-000051.md) | [6,349 d](/filings/0001075531-26-000009.md) | [5,532](/filings/0001075531-26-000025.md) | [7,352](/filings/0001075531-26-000037.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [3,103](/filings/0001075531-24-000048.md) | [609 d](/filings/0001075531-26-000009.md) | [791](/filings/0001075531-25-000024.md) | [1,856](/filings/0001075531-25-000036.md) | [3,179](/filings/0001075531-25-000051.md) | [1,729 d](/filings/0001075531-26-000009.md) | [1,062](/filings/0001075531-26-000025.md) | [2,250](/filings/0001075531-26-000037.md) | [3,483](/filings/0001075531-25-000051.md) | [2,030 d](/filings/0001075531-26-000009.md) | [1,271](/filings/0001075531-26-000025.md) | [2,500](/filings/0001075531-26-000037.md) |
| Interest expense | $m | [254](/filings/0001075531-23-000061.md) | [208 d](/filings/0001075531-24-000014.md) | [219](/filings/0001075531-24-000027.md) | [264](/filings/0001075531-25-000036.md) | [305](/filings/0001075531-25-000051.md) | [507 d](/filings/0001075531-26-000009.md) | [649](/filings/0001075531-26-000025.md) | [418](/filings/0001075531-26-000037.md) | [301](/filings/0001075531-25-000051.md) | [249 d](/filings/0001075531-26-000009.md) | [253](/filings/0001075531-26-000025.md) | [300](/filings/0001075531-26-000037.md) |
| Income tax | $m | [638](/filings/0001075531-24-000048.md) | [189 d](/filings/0001075531-26-000009.md) | [161](/filings/0001075531-25-000024.md) | [401](/filings/0001075531-25-000036.md) | [352](/filings/0001075531-25-000051.md) | [496 d](/filings/0001075531-26-000009.md) | [63.0](/filings/0001075531-26-000025.md) | [209](/filings/0001075531-26-000037.md) | [721](/filings/0001075531-25-000051.md) | [435 d](/filings/0001075531-26-000009.md) | [316](/filings/0001075531-26-000025.md) | [610](/filings/0001075531-26-000037.md) |
| Net income | $m | [2,511](/filings/0001075531-24-000048.md) | [222 d](/filings/0001075531-26-000009.md) | [776](/filings/0001075531-25-000024.md) | [1,521](/filings/0001075531-25-000036.md) | [2,517](/filings/0001075531-25-000051.md) | [1,068 d](/filings/0001075531-26-000009.md) | [333](/filings/0001075531-26-000025.md) | [895](/filings/0001075531-26-000037.md) | [2,748](/filings/0001075531-25-000051.md) | [1,428 d](/filings/0001075531-26-000009.md) | [1,083](/filings/0001075531-26-000025.md) | [1,950](/filings/0001075531-26-000037.md) |
| Diluted EPS | $ per share | [69.80](/filings/0001075531-24-000048.md) | not reported | [22.37](/filings/0001075531-25-000024.md) | [44.38](/filings/0001075531-25-000036.md) | [74.34](/filings/0001075531-25-000051.md) | not reported | [0.40](/filings/0001075531-26-000025.md) | [1.10](/filings/0001075531-26-000037.md) | [84.41](/filings/0001075531-25-000051.md) | not reported | [1.36](/filings/0001075531-26-000025.md) | [2.53](/filings/0001075531-26-000037.md) |
| Basic EPS | $ per share | [70.62](/filings/0001075531-24-000048.md) | not reported | [22.69](/filings/0001075531-25-000024.md) | [44.94](/filings/0001075531-25-000036.md) | [75.37](/filings/0001075531-25-000051.md) | not reported | [0.41](/filings/0001075531-26-000025.md) | [1.10](/filings/0001075531-26-000037.md) | [84.86](/filings/0001075531-25-000051.md) | not reported | [1.37](/filings/0001075531-26-000025.md) | [2.54](/filings/0001075531-26-000037.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [13.3](/filings/0001075531-23-000061.md) | [12.1](/filings/0001075531-25-000010.md) | [15.6](/filings/0001075531-24-000027.md) | [16.3](/filings/0001075531-24-000041.md) | [15.8](/filings/0001075531-24-000048.md) | [16.2](/filings/0001075531-26-000009.md) | [15.6](/filings/0001075531-25-000024.md) | [17.6](/filings/0001075531-25-000036.md) | [16.5](/filings/0001075531-25-000051.md) | [17.2](/filings/0001075531-26-000037.md) | [16.0](/filings/0001075531-26-000025.md) | [17.2](/filings/0001075531-26-000037.md) |
| Current assets | $bn | [18.5](/filings/0001075531-23-000061.md) | [17.0](/filings/0001075531-25-000010.md) | [20.5](/filings/0001075531-24-000027.md) | [21.3](/filings/0001075531-24-000041.md) | [20.5](/filings/0001075531-24-000048.md) | [20.5](/filings/0001075531-26-000009.md) | [20.0](/filings/0001075531-25-000024.md) | [23.3](/filings/0001075531-25-000036.md) | [21.7](/filings/0001075531-25-000051.md) | [22.3](/filings/0001075531-26-000037.md) | [20.9](/filings/0001075531-26-000025.md) | [23.1](/filings/0001075531-26-000037.md) |
| Total assets | $bn | [25.6](/filings/0001075531-23-000061.md) | [24.3](/filings/0001075531-25-000010.md) | [27.7](/filings/0001075531-24-000027.md) | [28.5](/filings/0001075531-24-000041.md) | [28.0](/filings/0001075531-24-000048.md) | [27.7](/filings/0001075531-26-000009.md) | [27.2](/filings/0001075531-25-000024.md) | [30.7](/filings/0001075531-25-000036.md) | [28.8](/filings/0001075531-25-000051.md) | [29.3](/filings/0001075531-26-000037.md) | [27.7](/filings/0001075531-26-000025.md) | [29.7](/filings/0001075531-26-000037.md) |
| Current liabilities | $bn | [12.8](/filings/0001075531-23-000061.md) | [13.3](/filings/0001075531-25-000010.md) | [16.8](/filings/0001075531-24-000027.md) | [18.2](/filings/0001075531-24-000041.md) | [16.7](/filings/0001075531-24-000048.md) | [15.6](/filings/0001075531-26-000009.md) | [16.4](/filings/0001075531-25-000024.md) | [18.6](/filings/0001075531-25-000036.md) | [16.3](/filings/0001075531-25-000051.md) | [16.7](/filings/0001075531-26-000037.md) | [19.8](/filings/0001075531-26-000025.md) | [21.1](/filings/0001075531-26-000037.md) |
| Total liabilities | $bn | [26.3](/filings/0001075531-23-000061.md) | [27.1](/filings/0001075531-25-000010.md) | [31.8](/filings/0001075531-24-000027.md) | [32.8](/filings/0001075531-24-000041.md) | [31.6](/filings/0001075531-24-000048.md) | [31.7](/filings/0001075531-26-000009.md) | [33.3](/filings/0001075531-25-000024.md) | [37.3](/filings/0001075531-25-000036.md) | [33.5](/filings/0001075531-25-000051.md) | [34.8](/filings/0001075531-26-000037.md) | [36.4](/filings/0001075531-26-000025.md) | [40.5](/filings/0001075531-26-000037.md) |
| Long-term debt | $bn | [11.9](/filings/0001075531-23-000061.md) | [12.2](/filings/0001075531-25-000010.md) | [13.4](/filings/0001075531-24-000027.md) | [13.4](/filings/0001075531-24-000041.md) | [13.8](/filings/0001075531-24-000048.md) | [14.9](/filings/0001075531-26-000009.md) | [15.4](/filings/0001075531-25-000024.md) | [17.5](/filings/0001075531-25-000036.md) | [16.0](/filings/0001075531-25-000051.md) | [16.9](/filings/0001075531-26-000037.md) | [15.4](/filings/0001075531-26-000025.md) | [18.2](/filings/0001075531-26-000037.md) |
| Current portion of debt | $bn | [1.9](/filings/0001075531-23-000061.md) | [2.0](/filings/0001075531-25-000010.md) | [3.5](/filings/0001075531-24-000027.md) | [3.4](/filings/0001075531-24-000041.md) | [2.4](/filings/0001075531-24-000048.md) | [1.7](/filings/0001075531-26-000009.md) | [0.7](/filings/0001075531-25-000024.md) | [1.0](/filings/0001075531-25-000036.md) | [1.0](/filings/0001075531-25-000051.md) | [1.9](/filings/0001075531-26-000037.md) | [3.0](/filings/0001075531-26-000025.md) | [2.0](/filings/0001075531-26-000037.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [(0.6)](/filings/0001075531-24-000048.md) | [(2.7)](/filings/0001075531-26-000009.md) | [(4.1)](/filings/0001075531-25-000036.md) | [(4.3)](/filings/0001075531-25-000051.md) | [(3.7)](/filings/0001075531-25-000051.md) | [(4.0)](/filings/0001075531-26-000037.md) | [(6.1)](/filings/0001075531-26-000037.md) | [(6.7)](/filings/0001075531-26-000037.md) | [(4.7)](/filings/0001075531-25-000051.md) | [(5.6)](/filings/0001075531-26-000037.md) | [(8.7)](/filings/0001075531-26-000037.md) | [(10.8)](/filings/0001075531-26-000037.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,372 d](/filings/0001075531-24-000048.md) | [1,346 d](/filings/0001075531-26-000009.md) | [2,704](/filings/0001075531-25-000024.md) | [2,525 d](/filings/0001075531-25-000036.md) | [2,373 d](/filings/0001075531-25-000051.md) | [721 d](/filings/0001075531-26-000009.md) | [3,283](/filings/0001075531-26-000025.md) | [3,201 d](/filings/0001075531-26-000037.md) | [1,435 d](/filings/0001075531-25-000051.md) | [1,490 d](/filings/0001075531-26-000009.md) | [3,215](/filings/0001075531-26-000025.md) | [3,719 d](/filings/0001075531-26-000037.md) |
| Capital expenditure | $m | [71.0 d](/filings/0001075531-24-000048.md) | [94.0 d](/filings/0001075531-26-000009.md) | [130](/filings/0001075531-25-000024.md) | [146 d](/filings/0001075531-25-000036.md) | [77.0 d](/filings/0001075531-25-000051.md) | [76.0 d](/filings/0001075531-26-000009.md) | [121](/filings/0001075531-26-000025.md) | [64.0 d](/filings/0001075531-26-000037.md) | [64.0 d](/filings/0001075531-25-000051.md) | [73.0 d](/filings/0001075531-26-000009.md) | [107](/filings/0001075531-26-000025.md) | [76.0 d](/filings/0001075531-26-000037.md) |
| Dividends paid | $m | [0.0 d](/filings/0001075531-24-000048.md) | [0.0 d](/filings/0001075531-26-000009.md) | [299](/filings/0001075531-25-000024.md) | [295 d](/filings/0001075531-25-000036.md) | [291 d](/filings/0001075531-25-000051.md) | [289 d](/filings/0001075531-26-000009.md) | [319](/filings/0001075531-26-000025.md) | [312 d](/filings/0001075531-26-000037.md) | [310 d](/filings/0001075531-25-000051.md) | [307 d](/filings/0001075531-26-000009.md) | [343](/filings/0001075531-26-000025.md) | [321 d](/filings/0001075531-26-000037.md) |
| Share repurchases | $m | [2,640 d](/filings/0001075531-24-000048.md) | [2,488 d](/filings/0001075531-26-000009.md) | [1,856](/filings/0001075531-25-000024.md) | [1,662 d](/filings/0001075531-25-000036.md) | [1,764 d](/filings/0001075531-25-000051.md) | [1,227 d](/filings/0001075531-26-000009.md) | [2,170](/filings/0001075531-26-000025.md) | [1,498 d](/filings/0001075531-26-000037.md) | [653 d](/filings/0001075531-25-000051.md) | [2,119 d](/filings/0001075531-26-000009.md) | [3,770](/filings/0001075531-26-000025.md) | [3,988 d](/filings/0001075531-26-000037.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [39.7](/filings/0001075531-23-000061.md) | [38.0](/filings/0001075531-24-000027.md) | [37.0](/filings/0001075531-24-000041.md) | [36.0](/filings/0001075531-24-000048.md) | [34.7](/filings/0001075531-25-000024.md) | [34.3](/filings/0001075531-25-000036.md) | [33.9](/filings/0001075531-25-000051.md) | [827](/filings/0001075531-26-000025.md) | [815](/filings/0001075531-26-000037.md) | [32.6](/filings/0001075531-25-000051.md) | [794](/filings/0001075531-26-000025.md) | [770](/filings/0001075531-26-000037.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 751,380,500 at 2026-07-27, from the cover of the [10-Q filed 2026-08-04](/filings/0001075531-26-000037.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.